A study using wearable devices to manage Long COVID symptoms
The Long COVID-19 Wearable Device Study
This study is testing if using wearable devices can help people with Long COVID manage their symptoms and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Scripps Translational Science Institute Academic / other |
| Locations | 1 site (La Jolla, California) |
| Trial ID | NCT05741112 on ClinicalTrials.gov |
What this trial studies
This study aims to better understand Long COVID by collecting data from individuals who either own wearable devices or are provided with one. Participants will be randomized into two groups: one will share data from their existing devices while receiving educational materials, and the other will receive a wearable device along with pacing education. The goal is to analyze the data and survey responses to improve symptom management and quality of life for those affected by Long COVID and related conditions. The study will include up to 100,000 participants, with a focus on post-exertional malaise.
Who should consider this trial
Good fit: Ideal candidates include adults diagnosed with Long COVID, ME/CFS, or POTS who are interested in using wearable technology for symptom management.
Not a fit: Patients without a diagnosis of Long COVID, ME/CFS, or POTS, or those not interested in using wearable devices may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights and tools for managing Long COVID symptoms, potentially improving patients' quality of life.
How similar studies have performed: Other studies utilizing wearable devices for chronic condition management have shown promise, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Is at least 18 years old. * Has a self/and or physician diagnosis of: * Long COVID (based on the WHO working definition), * ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or * POTS (Postural Orthostatic Tachycardia Syndrome). * Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms. * Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one. * Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly. * Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback. * Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventions such as medical treatment, self-management, and other interventional studies. * Agrees to complete at least 75% of the study surveys. Exclusion Criteria: * As long as they meet inclusion there is no exclusion
Where this trial is running
La Jolla, California
- Scripps Research — La Jolla, California, United States (Recruiting)
Study contacts
- Study coordinator: Andrea Goosen
- Email: agoosen@scripps.edu
- Phone: 0000000000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.